White House pulls Heidi Overton FDA nomination amid abortion-drug policy dispute
Susan B. Anthony Pro-Life America says it urged senators to pause Heidi Overton’s FDA nomination without Trump administration commitments on mifepristone policy, including ending mail-order access. The White House withdrew her nomination this week, citing insufficient Senate votes.
This is HUB News’s original summary. Read the complete report at Fox News.